BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 30350157)

  • 1. Response to the letter to the editor by Tsatsos et al. "To remove or not to remove (the AC-IOL)? This is the question. Letter regarding article Endothelial keratoplasty in eyes with a retained angle-supported intraocular lens by Droutsas et al.".
    Droutsas K; Lazaridis A; Kymionis G; Chatzistefanou K; Papaconstantinou D; Sekundo W; Koutsandrea C
    Int Ophthalmol; 2019 Sep; 39(9):1919. PubMed ID: 30350157
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter Regarding: Risk of Intraocular Lens Opacification After Endothelial Keratoplasty for Different Intraocular Lens Models: A Retrospective Single-Center Cohort Study.
    Terreros JP; Tello A; Galvis V; Berrospi RD; Villamizar SJ; Serrano SE
    Cornea; 2024 May; 43(5):e6. PubMed ID: 37986197
    [No Abstract]   [Full Text] [Related]  

  • 3. Authors' reply to the letter about comments on the article "Results of one decade of optical keratoplasty in pediatric patients".
    Morales-Flores N; Murillo-López AP; Pedro-Aguilar L; Graue-Hernández EO; Navas A
    Gac Med Mex; 2023; 159(4):362-363. PubMed ID: 37699213
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Letter to the Editor, Regarding Grauberger et al, 2020 and Sullivan et al, 2023.
    Sullivan MH; Wahlig BD; Broida SE; Larson AN; Shaughnessy WJ; Stans AA; Milbrandt TA
    J Pediatr Orthop; 2023 Nov-Dec 01; 43(10):e828-e829. PubMed ID: 37661838
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor: Does the origami plot really improve the radar plot? Comment on the article by Duan et al.
    Boers M
    J Clin Epidemiol; 2024 May; 169():111105. PubMed ID: 37301299
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to Letter to the Editor from deKemp, et al.
    Poitrasson-Rivière A; Murthy VL
    J Nucl Cardiol; 2021 Jun; 28(3):859-862. PubMed ID: 33851352
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the Editor in Response to Sengupta et al. (2022).
    Aboutorabi M; Ahmad M; Bray JJH
    Eur Heart J Qual Care Clin Outcomes; 2024 Jan; 10(1):104. PubMed ID: 37312271
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the editor in response to Chan et al. 2023.
    Thompson SE; Ahmad M
    Eur Heart J Cardiovasc Pharmacother; 2024 Jan; ():. PubMed ID: 38271609
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Letter to the Editor by Kim et al.
    Papi C; Iorio R
    Neurol Sci; 2023 Dec; 44(12):4535. PubMed ID: 37535126
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Letter to the Editor From Binghao Zhao et al.
    Girard N; Garassino MC; Solomon B
    J Thorac Oncol; 2023 Apr; 18(4):e40-e41. PubMed ID: 36990577
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to Buse et al.'s letter to the editor.
    Leimbigler B; Li EPH; Rush KL; Seaton CL
    Can J Public Health; 2023 Feb; 114(1):154-155. PubMed ID: 36520407
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Letter to the Editor From Nunez et al.
    DeMik DE; Carender CN; Bedard NA; Glass NA; Callaghan JJ; Brown TS
    J Arthroplasty; 2023 Feb; 38(2):e2. PubMed ID: 36608989
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to letter to the editor by Sterpetti et al.
    Douwes J; Whyte M; Ranta A
    J Neurol Sci; 2024 Mar; 458():122934. PubMed ID: 38423946
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to Letter to the Editor by Goupell et al.
    Aronoff JM; Staisloff HE
    Ear Hear; 2024 Mar-Apr 01; 45(2):527-528. PubMed ID: 38372760
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to a Letter to the Editor by Dr Fu-Shan Xue et al.
    Lindsey JT
    Ann Plast Surg; 2024 May; 92(5):603-604. PubMed ID: 38563563
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the editor in response to Komen et al. 2021.
    Kumar NS; Ahmed M
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e26. PubMed ID: 33711153
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to: Letter to the Editor by Trinh et al. Drug-induced liver injury registries are important.
    Björnsson ES; Lucena MI; Andrade RJ; Aithal GP
    Liver Int; 2023 Oct; 43(10):2325-2326. PubMed ID: 37592875
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to Letter to the Editor From Bouwmeester RN et al.: "Eculizumab in Postransplant TMA: Unproven Benefit.".
    Maritati F; La Manna G; Comai G
    Kidney Int Rep; 2024 Jun; 9(6):1930-1931. PubMed ID: 38899217
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to the letter to the Editor commenting on "Towards more relevance in forensic science research and development" by Weyermann et al.
    Weyermann C; Willis S; Margot P; Roux C
    Forensic Sci Int; 2024 Feb; 355():111928. PubMed ID: 38277914
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to Letter to the Editor from Janot et al: « Single-Exon Deletions of ZNRF3 Exon 2 cause Congenital Adrenal Hypoplasia ».
    Amano N; Narumi S; Ishii T; Hasegawa T
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38591244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.